Progression, Disease
11 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine Therapy (NCT06558084) | Ain Shams University | 2022-07-06 |
| Neuromelanin MRI: A Progression Marker in Early PD (NCT05631158) | University of Nottingham | 2020-11-01 |
| Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's Sarcoma (NCT03469804) | Assistance Publique - Hôpitaux de Paris | 2018-07-01 |
| A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy (NCT03150602) | Taiwan Mundipharma Pharmaceuticals Ltd. | 2016-08-30 |
| Energy for Lymphocytes (NCT04879316) | Hôpital Cochin | 2016-08-01 |
| SLNB After Neoadjuvant Treatment in Node Positive Patients (NCT03833960) | Clinical Hospital Center Rijeka | 2016-05-01 |
| Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy (NCT06170177) | IRCCS San Raffaele | 2013-02-04 |
Track Progression, Disease automatically
Every clearance here is in the API, with alerts when new ones post.